Tofacitinib 11mg Tablet in PCD pharma franchise in Hyderabad

Tofacitinib 11mg Tablet in pharmaceutical manufacturing company in Mumbai

Tofacitinib 11mg Tablet in anti-inflammatory pharma franchise in Pune

Tofacitinib 11mg Tablet in pharma suppliers in Delhi

Tofacitinib 11mg Tablet in pharma export companies in Kolkata
Tofacitinib 11mg Tablet in pharma franchise opportunities in Bengaluru

Tofatake ER 11 Tablet

Composition : Tofacitinib 11mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹499/-

Please Contact For Best Price

Tofatake ER 11 Tablet contains Tofacitinib 11mg in an extended-release formulation. Tofacitinib is a Janus kinase (JAK) inhibitor that modulates immune response by inhibiting JAK1 and JAK3 enzymes, which play a key role in the pathogenesis of inflammatory and autoimmune diseases. The extended-release version provides sustained drug levels over 24 hours, allowing for once-daily dosing, improving patient compliance and maintaining therapeutic efficacy throughout the day.

Tofatake ER 11 is indicated in the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, especially in patients who have had an inadequate response or intolerance to conventional disease-modifying antirheumatic drugs (DMARDs).

Read More

About the Product

Tofatake ER 11 Tablet contains Tofacitinib 11mg in an extended-release formulation. Tofacitinib is a Janus kinase (JAK) inhibitor that modulates immune response by inhibiting JAK1 and JAK3 enzymes, which play a key role in the pathogenesis of inflammatory and autoimmune diseases. The extended-release version provides sustained drug levels over 24 hours, allowing for once-daily dosing, improving patient compliance and maintaining therapeutic efficacy throughout the day.

Tofatake ER 11 is indicated in the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, especially in patients who have had an inadequate response or intolerance to conventional disease-modifying antirheumatic drugs (DMARDs).

Common side effects may include headache, diarrhea, nasopharyngitis, and hypertension. Serious risks include increased risk of infections, blood clots, elevated liver enzymes, and changes in blood lipid levels. Regular monitoring is recommended.

Tofatake ER 11 Tablet is indicated for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who have not responded adequately to previous DMARDs or biologic therapies. It helps reduce joint pain, stiffness, inflammation, and improves physical function in autoimmune conditions by controlling abnormal immune responses.

Use only under supervision of a specialist. Not recommended for use in patients with active serious infections, liver impairment, or those on strong immunosuppressants. Routine CBC, LFT, and lipid profile monitoring is advised during therapy.

Store in a cool, dry place away from direct sunlight.

Get in Touch